Cargando…

Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline

BACKGROUND: The Government of Indonesia implemented health technology assessment (HTA) to ensure quality and cost control in the National Health Insurance Program (Jaminan Kesehatan Nasional/JKN). The current aim of the study was to improve the usefulness of future economic evaluation for resource a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavarina, Kinanti Khansa, Faradiba, Dian, Sari, Ella Nanda, Wang, Yi, Teerawattananon, Yot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306002/
https://www.ncbi.nlm.nih.gov/pubmed/37383554
http://dx.doi.org/10.1016/j.lansea.2023.100184
_version_ 1785065849318539264
author Chavarina, Kinanti Khansa
Faradiba, Dian
Sari, Ella Nanda
Wang, Yi
Teerawattananon, Yot
author_facet Chavarina, Kinanti Khansa
Faradiba, Dian
Sari, Ella Nanda
Wang, Yi
Teerawattananon, Yot
author_sort Chavarina, Kinanti Khansa
collection PubMed
description BACKGROUND: The Government of Indonesia implemented health technology assessment (HTA) to ensure quality and cost control in the National Health Insurance Program (Jaminan Kesehatan Nasional/JKN). The current aim of the study was to improve the usefulness of future economic evaluation for resource allocation by appraising current methodology, reporting, and source of evidence quality of studies. METHODS: The inclusion and exclusion criteria were applied to search for relevant studies using a systematic review. The methodology and reporting adherence were appraised according to Indonesia's HTA Guideline issued in 2017. The differences in adherence before and after the guideline dissemination were compared using Chi-square and Fisher's exact tests for methodology adherence wherever appropriate, and the Mann–Whitney test for reporting adherence. The source of evidence quality was assessed using evidence hierarchy. Two scenarios of the study start date and the guideline dissemination period were tested using sensitivity analyses. FINDINGS: Eighty-four studies were obtained from PubMed, Embase, Ovid, and two local journals. Only two articles cited the guideline. No statistically significant difference (P > 0.05) was found between the pre-dissemination and post-dissemination period with respect to methodology adherence, except for outcome choice. Studies during the post-dissemination period showed a higher score for reporting which was statistically significant (P = 0.01). However, the sensitivity analyses revealed no statistically significant difference (P > 0.05) in methodology (except for modelling type, P = 0.03) and reporting adherence between the two periods. INTERPRETATION: The guideline did not impact the methodology and reporting standard used in the included studies. Recommendations were provided to improve the usefulness of economic evaluations for Indonesia. FUNDING: The Access and Delivery Partnership (ADP) hosted by the 10.13039/100016195United Nations Development Programme (UNDP) and the 10.13039/501100010724Health Systems Research Institute (HSRI).
format Online
Article
Text
id pubmed-10306002
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103060022023-06-28 Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline Chavarina, Kinanti Khansa Faradiba, Dian Sari, Ella Nanda Wang, Yi Teerawattananon, Yot Lancet Reg Health Southeast Asia Articles BACKGROUND: The Government of Indonesia implemented health technology assessment (HTA) to ensure quality and cost control in the National Health Insurance Program (Jaminan Kesehatan Nasional/JKN). The current aim of the study was to improve the usefulness of future economic evaluation for resource allocation by appraising current methodology, reporting, and source of evidence quality of studies. METHODS: The inclusion and exclusion criteria were applied to search for relevant studies using a systematic review. The methodology and reporting adherence were appraised according to Indonesia's HTA Guideline issued in 2017. The differences in adherence before and after the guideline dissemination were compared using Chi-square and Fisher's exact tests for methodology adherence wherever appropriate, and the Mann–Whitney test for reporting adherence. The source of evidence quality was assessed using evidence hierarchy. Two scenarios of the study start date and the guideline dissemination period were tested using sensitivity analyses. FINDINGS: Eighty-four studies were obtained from PubMed, Embase, Ovid, and two local journals. Only two articles cited the guideline. No statistically significant difference (P > 0.05) was found between the pre-dissemination and post-dissemination period with respect to methodology adherence, except for outcome choice. Studies during the post-dissemination period showed a higher score for reporting which was statistically significant (P = 0.01). However, the sensitivity analyses revealed no statistically significant difference (P > 0.05) in methodology (except for modelling type, P = 0.03) and reporting adherence between the two periods. INTERPRETATION: The guideline did not impact the methodology and reporting standard used in the included studies. Recommendations were provided to improve the usefulness of economic evaluations for Indonesia. FUNDING: The Access and Delivery Partnership (ADP) hosted by the 10.13039/100016195United Nations Development Programme (UNDP) and the 10.13039/501100010724Health Systems Research Institute (HSRI). Elsevier 2023-03-31 /pmc/articles/PMC10306002/ /pubmed/37383554 http://dx.doi.org/10.1016/j.lansea.2023.100184 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Chavarina, Kinanti Khansa
Faradiba, Dian
Sari, Ella Nanda
Wang, Yi
Teerawattananon, Yot
Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title_full Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title_fullStr Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title_full_unstemmed Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title_short Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline
title_sort health economic evaluations for indonesia: a systematic review assessing evidence quality and adherence to the indonesian health technology assessment (hta) guideline
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306002/
https://www.ncbi.nlm.nih.gov/pubmed/37383554
http://dx.doi.org/10.1016/j.lansea.2023.100184
work_keys_str_mv AT chavarinakinantikhansa healtheconomicevaluationsforindonesiaasystematicreviewassessingevidencequalityandadherencetotheindonesianhealthtechnologyassessmenthtaguideline
AT faradibadian healtheconomicevaluationsforindonesiaasystematicreviewassessingevidencequalityandadherencetotheindonesianhealthtechnologyassessmenthtaguideline
AT sariellananda healtheconomicevaluationsforindonesiaasystematicreviewassessingevidencequalityandadherencetotheindonesianhealthtechnologyassessmenthtaguideline
AT wangyi healtheconomicevaluationsforindonesiaasystematicreviewassessingevidencequalityandadherencetotheindonesianhealthtechnologyassessmenthtaguideline
AT teerawattananonyot healtheconomicevaluationsforindonesiaasystematicreviewassessingevidencequalityandadherencetotheindonesianhealthtechnologyassessmenthtaguideline